Hepatitis C Treatment Study in Myanmar
Condition:   Hepatitis C Intervention:   Drug: Sofosbuvir 400 mg Sponsor:   Myanmar Oxford Clinical Research Unit Not yet recruiting - verified May 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 16, 2017 Category: Research Source Type: clinical trials